T5	Material 153 170	a control subject
T8	Process 93 102	generated
T28	Material 448 480	patient-specific cellular models
T34	Material 668 681	staurosporine
T36	Material 721 753	the serine/threonine kinase S6K2
T39	Process 868 881	downregulated
T42	Material 935 952	kinase inhibitors
T45	Material 957 969	reduced S6K2
T46	Process 975 982	rescued
T51	Data 1025 1060	cell-autonomous, reversible defects
T52	Process 1146 1182	PGRN-dependent pathogenic mechanisms
T54	Process 1187 1194	testing
T55	Process 1195 1214	potential therapies
T63	Material 1457 1474	kinase inhibitors
T64	Process 1447 1453	stress
T65	Material 1477 1481	S6K2
T66	Process 1485 1498	downregulated
T67	Material 1502 1517	patient neurons
T68	Process 1521 1544	a PGRN-dependent manner
T82	Method 1804 1826	a human neuronal model
T83	Material 1905 1916	these lines
T84	Process 2124 2131	testing
T88	Method 1248 1268	A human neuron model
T97	Material 2055 2069	a model system
T98	Process 2083 2119	PGRN-dependent pathogenic mechanisms
T102	Material 1387 1392	iPSCs
T2	Material 103 147	multiple induced pluripotent stem cell lines
T4	Material 205 219	an FTD patient
T6	Process 225 285	a novel heterozygous GRN mutation (progranulin [PGRN] S116X)
T13	Process 484 507	PGRN haploinsufficiency
T14	Material 583 601	PGRN S116X neurons
T15	Material 611 631	sporadic FTD neurons
T18	Process 517 536	a systematic screen
T21	Data 643 664	increased sensitivity
T22	Material 686 709	other kinase inhibitors
T23	Material 770 849	the phosphatidylinositol 3-kinase and mitogen-activated protein kinase pathways
T24	Material 885 903	PGRN S116X neurons
T25	Data 910 931	increased sensitivity
T26	Process 986 1001	PGRN expression
T27	Material 1064 1079	patient neurons
T29	Data 1085 1100	PGRN deficiency
T30	Process 1272 1309	progranulin (PGRN) haploinsufficiency
T31	Material 1327 1386	Sporadic and PGRN-deficient frontotemporal dementia patient
T32	Material 1404 1429	PGRN S116X mutant neurons
T33	Process 1545 1573	Progranulin (PGRN) mutations
T35	Process 1596 1619	frontotemporal dementia
T40	Process 1830 1853	PGRN haploinsufficiency
T41	Material 1866 1891	human postmitotic neurons
T43	Process 1924 1962	cell-autonomous and reversible defects
T44	Material 2018 2040	PGRN-deficient neurons
T1	Process 0 58	The pathogenic mechanisms of frontotemporal dementia (FTD)
T10	Material 172 181	a patient
T11	Process 187 199	sporadic FTD
T3	Material 1704 1789	multiple frontotemporal dementia patient-specific induced pluripotent stem cell lines
T17	Process 2132 2151	potential therapies
T16	Material 290 297	neurons
T38	Material 302 311	microglia
T7	Material 332 373	PGRN S116X induced pluripotent stem cells
T9	Data 375 385	the levels
T12	Material 389 420	intracellular and secreted PGRN
T19	Material 540 548	inducers
T20	Process 552 567	cellular stress
T47	Process 1137 1145	studying
T37	Process 1625 1659	the underlying molecular mechanism
T48	Material 1966 1993	specific signaling pathways
T49	Process 2074 2082	studying
